The clinical performance is complex and often involves multi-system fatigue. Early identification and standardized clinical care are essential for improving prognosis. The diagnosis of the disease requires a combination of clinical performance, imaging inspection, laboratory testing and pathological evaluation.
The platform can assist in linking a team of authoritative experts at home and abroad to provide accurate diagnosis and treatment. Treatment and management of the treatment of IBD requires the development of personalized treatment, usually pharmacotherapy, rehabilitation intervention, regular follow-up, and other multidimensional management. In recent years, with the development of therapeutic, immune-regulatory therapy and precision medicine, many previously difficult to treat infectious respiratory digestive endocrine disorders have been significantly improved.
Therapeutic efficacy and adverse reactions need to be closely monitored and timely adjusted according to changes in the course of treatment. Multidisciplinary collaboration (MDT) is particularly important for the integrated management of IBD-associated osteoporosis. The platform serves a team of domestic and foreign experts in the field of infectious respiratory digestive endocrine services in China.
2. Visiting China: arranging face-to-face treatment with authoritative experts, developing individualized treatment plans; 3. Full-service: providing one-stop services such as medical translation, medical care, accommodation arrangements; 4.
Long-term follow-up: establishing a chronic disease management archive, continuous monitoring of disease changes and treatment effects.